Approximately 4 million patients annually receive life-saving transfusions of blood donated by 14 million donors around the nation. This report evaluates the Food and Drug Administration's qlayers of safetyq that provide the framework for regulating and monitoring the U.S. blood industry. Specifically, it examines the actual and potential vulnerabilities in the layers of safety that may present a threat to the public health. Addresses these potential vulnerabilities in light of changes in the blood industry that have occurred since the mid-1980s, when there was widespread concern about the safety of the nation's blood supply. Viral and non-viral agents are described.4 Furthermore, the aabb technical manual states that when it is necessary to destroy a product, the identification of each of the components destroyed, the reasons for destruction, and the data and methods of destruction must be recorded.5anbsp;...
|Author||:||Marcia G. Crosse|
|Publisher||:||DIANE Publishing - 1999-02-01|